Growth Metrics

LifeStance Health (LFST) Leases (2022 - 2025)

LifeStance Health (LFST) has disclosed Leases for 4 consecutive years, with $149.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Leases rose 1.25% to $149.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $149.7 million, a 1.25% increase, with the full-year FY2025 number at $149.7 million, up 1.25% from a year prior.
  • Leases was $149.7 million for Q4 2025 at LifeStance Health, up from $145.7 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $199.4 million in Q4 2022 to a low of $143.2 million in Q2 2025.
  • A 4-year average of $165.7 million and a median of $160.2 million in 2024 define the central range for Leases.
  • Peak YoY movement for Leases: decreased 16.29% in 2024, then increased 1.25% in 2025.
  • LifeStance Health's Leases stood at $199.4 million in 2022, then fell by 14.4% to $170.7 million in 2023, then decreased by 13.37% to $147.9 million in 2024, then increased by 1.25% to $149.7 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Leases are $149.7 million (Q4 2025), $145.7 million (Q3 2025), and $143.2 million (Q2 2025).